Scientists identify immune pathway driving allergic rhinitis

Researchers have pinpointed a specific molecular mechanism—involving Notch signaling proteins—that appears to drive allergic rhinitis, the chronic inflammation affecting millions worldwide. The finding could unlock new drug targets for a condition that currently relies on symptom management, potentially opening a market for disease-modifying treatments.

Originaltitel: Upregulated expression of Notch1/4-JAG-1/DLL-1 detected in allergic rhinitis